Optimizing the Clinical Relevancy of Animal Model Studies

Time: 9:30 am
day: Conference Day Two


  • Exploring the need for using both mouse models of retinal degeneration and wild-type large animal models for better understanding protein expression and function levels
  • Finetuning the applicability of endpoints in animal models ahead of clinical trials
  • What does the FDA expect to see from animal model studies in your IND submission?